Dr. Andrew Manganaro is the Chief Medical Officer and National Medical Director for Life Line Screening. He is a graduate of the New York University School of Medicine where he earned his M.D. After completing his residency and chief residency in general surgery as well as a chief residency in cardiothoracic and vascular surgery he earned his board certification in Thoracic Surgery. The next 35 years of his professional career were spent in private practice where he completed cardiac, vascular, and thoracic surgeries. Once Dr. Manganaro left private practice he joined Life Line Screening.
During his career as a surgeon Dr. Andrew Mananaro saw many patients who could have been helped if their conditions had been spotted far earlier. Instead it took a catastrophe before they were aware of their serious health conditions. He says that Life Line Screening does exactly this, helping people find out about their medical condition before they end up in an emergency room. Once knowledgable about their conditions they can make changes in their life such as what they eat and how much the exercise. They can also be prescribed medicines by their primary care physcians in order to treat their issue.
So far, Life Line Screening has screened over 8 million people. In addition to helping the person getting the screening, their information also helps inform medical research. Their information (which is anonymous) is fed into a database which comprises one of the largest of its kind in the world. This database is uses by medical researchers and has been used in peer reviewed medical journals around the world.
Life Line Screening provides three types of testing during their screenings. They use an ultrasound machine that can spot abdominal aortas, carotid arteries, and vascular diseases. The EKG screening can show atrial fibrillation which is a condition that can lead to strokes. The also offer blood tests which are used for determing cholesterol levels, triglyceride counts, and other basic information about the person. Soon they will be able to spot the early signs of adult onset diabetes through a new screening.
To know more visit @ www.glassdoor.com/Salary/Life-Line-Screening-Salaries-E647033.htm
A new clinical trial called HALT-MS has shown promising results in inducing the long term remission of relapsing-remitting multiple sclerosis, also known as MS. MS is an autoimmune disease where the body’s immune system attacks the central nervous system.
MS symptoms vary widely across patients, but can include speech and motor impairment, weakness, fatigue, and chronic pain. The most common type of MS is relapsing-remitting MS. This form of MS is depicted by periods of little to no symptoms followed by relapses which are likely to worsen over time, eventually turning into a progressive form of MS.
The HALT-MS study involved the procedure of collecting a patient’s stem cells, giving the patient a high dose of chemotherapy in order to deplete the immune system, and then returning the stem cells back into the body in order to rebuild the immune system.
The results of the study showed that 69 percent of trial participants went without experiencing progression or relapse of the disease. Other studies involving currently available MS drugs showed lower success rates. Five years after the study, many trial participants remained in remission. Some participants had even shown improvement in the area of mobility and other physical abilities once hindered from the disease. While more research is necessary, these are very promising results.
Dr. Shiva Gopal Vasishta is a neurologist located in Vorhees, New Jersey. He graduated from Government Medical College and completed his residency at Tufts Medical Center and Boston University Medical Center. Dr. Gopal Vasishta has been practicing medicine for almost 40 years.
Dr. Gopal Vasishta currently practices at Eastern Neurodiagnostic Associates and is affiliated with Kennedy University Hospital. He is one of 34 doctors at the hospital that specialize in neurology. In addition to neurology, Dr. Gopal Vasishta also specializes in Psychiatry.